Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutation Cholangiocarcinoma
Condition: Cholangiocarcinoma Intervention: Drug: GNS561 + Trametinib Sponsor: Genfit Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials